Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Chronic Lower Back Pain Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Chronic Lower Back Pain Trends and Forecast

The future of the global chronic lower back pain market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global chronic lower back pain market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising number of instances of strained muscles or ligaments brought on by abrupt movements, heavy lifting, and bad posture, rise in the number of elderly people and an increase in nerve cases globally.
Chronic Lower Back Pain Trends and Forecast

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Chronic Lower Back Pain by Segment

Chronic Lower Back Pain by Segment

The study includes a forecast for the global chronic lower back pain by drug class, route of administration, end-use, and region.

Chronic Lower Back Pain Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:


• Non-Steroidal Anti-Inflammatory Drugs
• Antidepressants
• Analgesics
• Opioids
• Others

Chronic Lower Back Pain Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:


• Oral
• Topical
• Others

Chronic Lower Back Pain Market by End-Use [Shipment Analysis by Value from 2018 to 2030]:


• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Chronic Lower Back Pain Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Chronic Lower Back Pain Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic lower back pain companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic lower back pain companies profiled in this report include-
• Johnson & Johnson Services
• Pfizer
• Vertebral Technologies
• Merck & Co.
• Medtronic
• Boston Scientific
• Mesoblast
• SpineThera
• Stayble Therapeutics
• Eli Lilly & Company

Chronic Lower Back Pain Market Insights

Lucintel forecasts that analgesic is expected to witness the highest growth over the forecast period.
Within this market, hospital pharmacy is expected to witness the highest growth.
North America is expected to witness highest growth over the forecast period because the pharma companies are concentrating on the research and development of cutting-edge pharmaceuticals due to the necessity for progressive therapy.

Features of the Global Chronic Lower Back Pain Market

Market Size Estimates: Chronic lower back pain market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Chronic lower back pain market size by drug class, route of administration, end-use, and region in terms of value ($B).
Regional Analysis: Chronic lower back pain market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug class, route of administration, end-use, and regions for the chronic lower back pain market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic lower back pain market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for chronic lower back pain market?
Answer: The global chronic lower back pain market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the chronic lower back pain market?
Answer: The major drivers for this market are rising number of instances of strained muscles or ligaments brought on by abrupt movements, heavy lifting, and bad posture, rise in the number of elderly people and an increase in nerve cases globally.
Q3. What are the major segments for chronic lower back pain market?
Answer: The future of the global chronic lower back pain market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.
Q4. Who are the key chronic lower back pain market companies?
Answer: Some of the key chronic lower back pain companies are as follows:
• Johnson & Johnson Services
• Pfizer
• Vertebral Technologies
• Merck & Co.
• Medtronic
• Boston Scientific
• Mesoblast
• SpineThera
• Stayble Therapeutics
• Eli Lilly & Company
Q5. Which chronic lower back pain market segment will be the largest in future?
Answer: Lucintel forecasts that analgesic is expected to witness the highest growth over the forecast period.
Q6. In chronic lower back pain market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period because the pharma companies are concentrating on the research and development of cutting-edge pharmaceuticals due to the necessity for progressive therapy.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the chronic lower back pain market by drug class (non-steroidal anti-inflammatory drugs, antidepressants, analgesics, opioids, and others), route of administration (oral, topical, and others), end-use (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Chronic Lower Back Pain Market, Chronic Lower Back Pain Market Size, Chronic Lower Back Pain Market Growth, Chronic Lower Back Pain Market Analysis, Chronic Lower Back Pain Market Report, Chronic Lower Back Pain Market Share, Chronic Lower Back Pain Market Trends, Chronic Lower Back Pain Market Forecast, Chronic Lower Back Pain Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Chronic Lower Back Pain Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Chronic Lower Back Pain Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Chronic Lower Back Pain Market by Drug Class
3.3.1: Non-Steroidal Anti-Inflammatory Drugs
3.3.2: Antidepressants
3.3.3: Analgesics
3.3.4: Opioids
3.3.5: Others
3.4: Global Chronic Lower Back Pain Market by Route of Administration
3.4.1: Oral
3.4.2: Topical
3.4.3: Others
3.5: Global Chronic Lower Back Pain Market by End-Use
3.5.1: Hospital Pharmacies
3.5.2: Retail Pharmacies
3.5.3: Online Pharmacies
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Chronic Lower Back Pain Market by Region
4.2: North American Chronic Lower Back Pain Market
4.2.1: North American Chronic Lower Back Pain Market by Drug Class: Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesics, Opioids, and Others
4.2.2: North American Chronic Lower Back Pain Market by End-Use: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Chronic Lower Back Pain Market
4.3.1: European Chronic Lower Back Pain Market by Drug Class: Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesics, Opioids, and Others
4.3.2: European Chronic Lower Back Pain Market by End-Use: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Chronic Lower Back Pain Market
4.4.1: APAC Chronic Lower Back Pain Market by Drug Class: Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesics, Opioids, and Others
4.4.2: APAC Chronic Lower Back Pain Market by End-Use: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Chronic Lower Back Pain Market
4.5.1: ROW Chronic Lower Back Pain Market by Drug Class: Non-Steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesics, Opioids, and Others
4.5.2: ROW Chronic Lower Back Pain Market by End-Use: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Chronic Lower Back Pain Market by Drug Class
6.1.2: Growth Opportunities for the Global Chronic Lower Back Pain Market by Route of Administration
6.1.3: Growth Opportunities for the Global Chronic Lower Back Pain Market by End-Use
6.1.4: Growth Opportunities for the Global Chronic Lower Back Pain Market by Region
6.2: Emerging Trends in the Global Chronic Lower Back Pain Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Chronic Lower Back Pain Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Lower Back Pain Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Johnson & Johnson Services
7.2: Pfizer
7.3: Vertebral Technologies
7.4: Merck & Co.
7.5: Medtronic
7.6: Boston Scientific
7.7: Mesoblast
7.8: SpineThera
7.9: Stayble Therapeutics
7.10: Eli Lilly & Company
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Chronic Lower Back Pain Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.